Professional Documents
Culture Documents
• Follow Up Visit
• Medication
History Investigation
Demonstrate
airway
airflow
obstruction
obstruction
variability
Spirometry Bronchodilator ICS
Reversibility reversibility
An improvement An improvement
A FEV1/FVC ratio of <70%
in FEV1 of ≥12% in FEV1 of ≥12%
is a positive test for
AND ≥200 ml AND ≥200 ml
obstructive airway
(or PEF >20%)
disease
Self Monitoring
(symptoms &/or PEF)
Asthma Self
Management
Written Asthma Action Plan (WAAP)
1) Symptoms Control
Assessment of Asthma
Control
Night awakening
Activity limitation
in past 4 weeks
2) Risk Factor for Poor Outcome
1 <2x/month + - + - + -
2x/month -
2 or ≥1x/month + - + -
2x/week
• Types of hyperlipidemia
• Target Level
• Management
Types of
Hyperlipidemia
Composition/ Etiology
Percentage of (Primary/
Serum Lipids Secondary)
Composition/Percentage
of Serum Lipids
Lipoprotein
structure
• There are four major classes of circulating lipoproteins, each with its
own characteristic protein and lipid composition(cholesterol & TG).
They are chylomicrons, very low-density lipoproteins (VLDL), low-
density lipoproteins (LDL), and high-density lipoproteins (HDL).
TG
TC
Etiology
(Primary/Secondary)
When to consider SECONDARY causes of dyslipidemia:
Specific Lipid
Criteria
Abnormalities
TC >5.2 mmol/L
specific goal:
non HDL-C 0.8 mmol/L higher than
the corresponding LDL-C.
Management
A. Therapeutic Lifestyle
Changes (TLC)
• The recommended total fat intake for healthy adults is between 20 to
25% with an upper limit of 30% of total energy intake.
• The intake of SFA (saturated fat) should not exceed 10% of energy
intake.
• TFA (trans fat) intake should be kept at less than 1% of total energy.